Sajad Yaghoubi

Sajad Yaghoubi

Auto-generated profile, based on publicly available information

Sajad Yaghoubi

Department of Clinical Microbiology, Iranshahr University of Medical Sciences, Iranshahr, Iran

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2020 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
MMMotahareh Mahi-Birjand
Motahareh Mahi-Birjand
SYSajad Yaghoubi
Sajad Yaghoubi
MAMeghdad Abdollahpour-Alitappeh
Meghdad Abdollahpour-Alitappeh
ZKZahra Keshtkaran
Zahra Keshtkaran
NBNader Bagheri
Nader Bagheri
IKIman Karimzadeh
Iman Karimzadeh
Introduction: Aminoglycosides have long been used in antibacterial treatment and are still commonly used in clinical practice. Despite their extensive application and positive effects, drug-related toxicity is considered as the main obstacle of aminoglycosides. Aminoglycosides induce nephrotoxicity through the endocytosis and accumulation of the antibiotics in the epithelial cells of proximal tubule. Most importantly, however, a number of pharmacological agents were demonstrated to have protective activities against nephrotoxicity in experimental animals. Areas covered: In the present systemic review, the authors provide and discuss the mechanisms and epidemiological features of aminoglycoside-induced nephrotoxicity, and focus mainly on recent discoveries and key features of pharmacological interventions. In total, 39 articles were included in this review. Expert opinion: The majority of studies investigated gentamicin-induced nephrotoxicity in animal models. Antioxidants, chemicals, synthetic drugs, hormones, vitamins, and minerals showed potential values to prevent gentamicin-induced nephrotoxicity. Indicators used to evaluate the effectiveness of nephroprotection included antioxidative indexes, inflammatory responses, and apoptotic markers. Among the nephroprotective agents studied, herbs and natural antioxidant agents showed excellent potential to provide a protective strategy against gentamicin-induced nephrotoxicity.

1 May 2024 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
ADAtieh Darbandi
Atieh Darbandi
MAMilad Abdi
Milad Abdi
SDShirin Dashtbin
Shirin Dashtbin
SYSajad Yaghoubi
Sajad Yaghoubi
MSMohammad Sholeh
Mohammad Sholeh
BTBehrouz Taheri
Behrouz Taheri
Introduction: Antibodies are significant agents in the immune system and have proven to be effective in treating bacterial infections. With the advancement of antibody engineering in recent decades, antibody therapy has evolved widely.Aim: This review aimed to investigate a new method as a therapeutic platform for the treatment of bacterial infections and explore the novel features of this method in conferring pathogen specificity to broad‐spectrum antibiotics.Material and Methods: A literature review was conducted addressing the following topics about antibody–antibiotic conjugates (AACs): (1) structure and mechanism of action; (2) clinical effectiveness; (3) advantages and disadvantages.Result: Antibody conjugates are designed to build upon the progress made in the development of monoclonal antibodies for the treatment of diseases. Despite the growing emergence of antibiotic resistance among pathogenic bacteria worldwide, novel antimicrobials have not been sufficiently expanded to combat the global crisis of antibiotic resistance. A recently developed strategy for the treatment of infectious diseases is the use of AACs, which are specifically activated only in host cells.Conclusion: A novel therapeutic AAC employs an antibody to deliver the antibiotic to the bacteria. The AACs can release potent antibacterial components that unconjugated forms may not exhibit with an appropriate therapeutic index. This review highlights how this science has guided the design principles of an impressive AAC and discusses how the AAC model promises to enhance the antibiotic effect against bacterial infections.

9 September 2021 in New Microbes and New Infections
Verified
Journal Article
Open access
ZBZ. Baseri
Z. Baseri
ADA. Dehghan
A. Dehghan
SYS. Yaghoubi
S. Yaghoubi
SRSh. Razavi
Sh. Razavi
Stenotrophomonas maltophilia has emerged as an important nosocomial pathogen. Treatment of S. maltophilia infections is difficult due to increasing resistance to multiple antibacterial agents. In this 12-month cross-sectional study, from 2017 to 2018, 117 isolates were obtained from different clinical sources and identified by conventional biochemical methods. Antibiotic susceptibility tests were performed according to CLSI 2018. Minocycline disk (30 μg) and E-test strips for ceftazidime, trimethoprim-sulfamethoxazole and chloramphenicol were used. PCR confirmed isolates. The frequency of different classes of integrons (I, II) and resistance gene cassettes (sul1, sul2, dfrA1, dfrA5 and aadB) were determined by PCR. The results showed the highest frequency of resistance to chloramphenicol and ceftazidime with 32 cases (27.11%). Among strains, 12 cases (10.25%) were resistant to trimethoprim-sulfamethoxazole (the lowest frequency of resistance), while 19 (16.1%) isolates were resistant to minocycline. Frequency of sul1, int1, aadB, sul2, dfrA5 genes were 64 (55.08%), 26 (22.3 %), 18 (15.25%) and 17 (14.4%), 14 (11.86%), respectively. int2 and dfrA1 were not detected. Although we have not yet reached a high level of resistance to effective antibiotics such as trimethoprim-sulfamethoxazole, as these resistances can be carried by a plasmid, greater precision should be given to the administration of these antibiotics.

1 January 2021 in Indian Journal of Medical Microbiology
Verified
Journal Article
Closed access
EKEbrahim Kouhsari
Ebrahim Kouhsari
KAKhalil Azizian
Khalil Azizian
MSMohammad Sholeh
Mohammad Sholeh
MSMohammad Shayestehpour
Mohammad Shayestehpour
MHMarzieh Hashemian
Marzieh Hashemian
NSNourkhoda Sadeghiifard
Nourkhoda Sadeghiifard

29 July 2020 in Substance Abuse Treatment, Prevention, and Policy
Verified
Journal Article
Open access
PDF file
ESEbrahim Moghimi Sarani
Ebrahim Moghimi Sarani
JAJamshid Ahmadi
Jamshid Ahmadi
BOBahare Oji
Bahare Oji
MMMotahareh Mahi-Birjand
Motahareh Mahi-Birjand
NBNader Bagheri
Nader Bagheri
MAMeghdad Abdollahpour-Alitappeh
Meghdad Abdollahpour-Alitappeh
Background: Methamphetamine (MA) remains one of the most commonly used amphetamine-type stimulants, accounting for the second most widely-used substance after marijuana. Due to increased use of MA, a wide variety of research has focused on the patterns of MA use initiation among adolescents. Nevertheless, there are few data available for people who use MA. The present study set out to assess the sequential patterns of substance use initiation in patients with MA use disorders in Iran. Materials and methods: This cross-sectional study described substance initiation patterns for 302 patients who used MA admitted to hospitals and psychiatric centers of Shiraz University of Medical Sciences. The study was conducted between April 2015 and June 2016. After obtaining informed consents, participants were interviewed by trained interviewers using face-to-face, semi-structured interviews. The collecting data were analyzed using the chi square tests and one-way analysis of variance (ANOVA) tests to compare the relationship between qualitative and quantitative variables, respectively. Results: Out of 302 participants enrolled in the study, 16 (5.3%) and 286 (94.7%) were female and male, respectively. The mean age of participants in the study was 37.29 years. The mean age of onset of MA use was found to be 15.9 years. 46.1% of the patients started MA use before 15 years. 77.2% of the patients who used MA had family members with a history of substance use. 93.71% of the patients who used MA started substance use with tobacco, alcohol, or opium, as the most frequent substances. Tobacco, as the first substance or starting substance, exhibited the most widely-used substance (69.53% of the cases). Tobacco-alcohol-cannabis-opium-heroin-MA sequencing was significantly related to the early onset of the substance use. Early-onset substance use was significantly higher in those with lower income, primary education, and family history of substance use. No significant relationship was found between employment status with the age of onset of substance use, and different substance use with marital status. Conclusion: Tobacco, alcohol and opium can be considered as the main sequencing substances for initiation to MA use. Standardized measures to decrease and control access to main starting and sequencing substances, including tobacco, alcohol, and opium, can greatly help decrease the early onset of the MA use, develop suitable prevention, and establish early intervention strategies.

30 June 2026 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
MBMaryam Beiranvand
Maryam Beiranvand
SASaeid Afshar
Saeid Afshar
Abdolrazagh Hashemi ShahrakiAbdolrazagh Hashemi Shahraki
Abdolrazagh Hashemi Shahraki
SYSajad Yaghoubi
Sajad Yaghoubi
HSHadi Samadian
Hadi Samadian
Background: Multidrug-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA), pose a major global health threat and cause hundreds of thousands of deaths annually. Endophytic Streptomyces strains are promising sources of bioactive metabolites; however, many of their biosynthetic gene clusters remain silent under standard laboratory conditions. Objectives: This study aimed to activate silent biosynthetic pathways in an endophytic Streptomyces isolate using the one strain–many compounds (OSMAC) strategy to enhance the production of metabolites with anti-MRSA activity. Methods: An endophytic Streptomyces strain was isolated from medicinal plants in Iran. The OSMAC approach was applied by systematically varying key culture parameters, including nutrient composition, pH, aeration, incubation time, and the physicochemical conditions of the medium. Light regimes were also optimized to better simulate the bacterium’s natural habitat. The antibacterial activity of the extracts was evaluated against MRSA ATCC 43300 using the standard agar well diffusion method. Results: Optimization of culture conditions significantly increased the production of secondary metabolites with potent anti-MRSA activity. The largest inhibition zones were achieved under specific combinations of nutrient limitation, a slightly acidic pH, and defined light exposure, compared with standard laboratory conditions. Conclusions: This study highlights the OSMAC strategy as an effective and cost-efficient method for activating silent biosynthetic pathways in endophytic Streptomyces by manipulating culture conditions. The optimized approach provides a valuable framework for discovering novel anti-MRSA compounds from actinobacteria.